Stockreport

GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen's Iqirvo® for Primary Biliary Cholangitis [Yahoo! Finance]

GENFIT S.A. - American Depositary Shares  (GNFT) 
PDF First-ever drug developed in-house by GENFIT to achieve U.S. FDA's approval GENFIT is eligible to receive a €48.7 million milestone payment from Ipsen upon the first [Read more]